WBR0361
Jump to navigation
Jump to search
Author | PageAuthor::Neeraja Danda M.B.B.S |
---|---|
Exam Type | ExamType::USMLE Step 2 CK |
Main Category | MainCategory::Internal medicine |
Sub Category | SubCategory::Cardiovascular |
Prompt | [[Prompt::A 60 year old male who developed sudden chest pain associated with excessive sweating while having his lunch is brought to the emergency department . Electrocardiogram shows ST segment depression in leads V2-V4. Aspirin, Oxygen, Morphine and nitrates are given.Which of the following therapeutics are associated with a major mortality benefit in this patient?]] |
Answer A | AnswerA::Thrombolysis |
Answer A Explanation | AnswerAExp::'''Incorrect''' Thrombolysis is never the treatment of choice in Non ST elevation or ST depression Myocardial infarction |
Answer B | AnswerB::Exercise tolerance testing |
Answer B Explanation | AnswerBExp::'''Incorrect''' Exercise tolerance testing is performed to assess if the patient’s heart muscle getting enough oxygen in exertion. It does not confer any mortality benefit. |
Answer C | AnswerC::Nitroglycerine |
Answer C Explanation | AnswerCExp::'''Incorrect''' Nitroglycerine is useful but does not have clear mortality benefits |
Answer D | AnswerD::Heparin, Glycoprotein IIb, IIIa inhibitors |
Answer D Explanation | AnswerDExp::'''Incorrect''' Option D is also correct but E includes angioplasty as well which makes it the best option |
Answer E | AnswerE::Heparin, Glycoprotein IIb , IIIa inhibitors and Angioplasty |
Answer E Explanation | AnswerEExp::Heparin, Glycoprotein IIb, IIIa inhibitors like Abciximab, tirofiban , Epifibatide and Angioplasty offer a significant mortality benefit in Non ST elevation myocardial infarction or ST depression infarctions. |
Right Answer | RightAnswer::E |
Explanation | [[Explanation::Heparin, Glycoprotein IIb, IIIa inhibitors like Abciximab, tirofiban , Epifibatide and Angioplasty offer a significant mortality benefit in this patient.
Educational Objective: Heparin, Glycoprotein IIb, IIIa inhibitors like Abciximab, tirofiban , Epifibatide and Angioplasty offer great mortality benefits in ST depression or Non ST elevation myocardial infarction. References: page 49 Master the boards Step 3 2009 edition, Page 69 Master the boards Step 2 CK second edition |
Approved | Approved::Yes |
Keyword | |
Linked Question | Linked:: |
Order in Linked Questions | LinkedOrder:: |